Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Eurofins Scientific | Paris | Healthcare | Biotechnology & Medical Research | €11.33B | 33.3x | 0.73 | €58.82 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -6.4% Downside | Upgrade to Pro+ | |
Valneva | Paris | Healthcare | Biotechnology & Medical Research | €464.61M | -5.4x | 0.03 | €2.73 | 2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Abivax SA | Paris | Healthcare | Biotechnology & Medical Research | €422.49M | -0.21 | €6.66 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Inventiva | Paris | Healthcare | Biotechnology & Medical Research | €412.10M | -0.9x | 0.08 | €2.96 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Eurobio Scientific | Paris | Healthcare | Biotechnology & Medical Research | €253.87M | 65.1x | -6.44 | €25.30 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 24.2% Upside | Upgrade to Pro+ | |
Nanobiotix | Paris | Healthcare | Biotechnology & Medical Research | €203.84M | -2x | 0.08 | €4.30 | 4.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Genfit | Paris | Healthcare | Biotechnology & Medical Research | €189.79M | 123.7x | 1.25 | €3.81 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Innate Pharma | Paris | Healthcare | Biotechnology & Medical Research | €164.59M | -3.4x | 0.01 | €1.79 | -5.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Transgene | Paris | Healthcare | Biotechnology & Medical Research | €128.24M | -2x | 0.13 | €0.97 | -3.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 29.6% Upside | Upgrade to Pro+ | |
Ose Pharma International SA | Paris | Healthcare | Biotechnology & Medical Research | €122.69M | 4.1x | 0.02 | €5.49 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sensorion SA | Paris | Healthcare | Biotechnology & Medical Research | €118.69M | -1.8x | -0.09 | €0.40 | -2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Eurofins-Cerep | Paris | Healthcare | Biotechnology & Medical Research | €103.91M | €20,600 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Cellectis | Paris | Healthcare | Biotechnology & Medical Research | €93.25M | -2.6x | -0.03 | €1.29 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Maat Pharma | Paris | Healthcare | Biotechnology & Medical Research | €82.03M | -2.7x | 0.1 | €5.10 | -5.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Adocia | Paris | Healthcare | Biotechnology & Medical Research | €64.24M | -5.9x | -0.1 | €3.56 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Fermentalg | Paris | Healthcare | Biotechnology & Medical Research | €47.81M | -3.1x | -0.08 | €0.53 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 36.2% Upside | Upgrade to Pro+ | |
Abionyx Pharma SA | Paris | Healthcare | Biotechnology & Medical Research | €44.59M | -9.4x | 1.23 | €1.29 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Novacyt | Paris | Healthcare | Biotechnology & Medical Research | €40.21M | -1.1x | 0.02 | €0.57 | 3.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Poxel SA | Paris | Healthcare | Biotechnology & Medical Research | €34.35M | -0.4x | -0.04 | €0.64 | -7.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Genoway | Paris | Healthcare | Biotechnology & Medical Research | €32.18M | €3.49 | 2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Gensight Biologics | Paris | Healthcare | Biotechnology & Medical Research | €26.60M | -1.9x | -0.03 | €0.20 | 5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
NFL Biosciences | Paris | Healthcare | Biotechnology & Medical Research | €14.78M | -6.4x | -0.11 | €1.16 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Valbiotis | Paris | Healthcare | Biotechnology & Medical Research | €14.07M | -1.8x | 0.25 | €0.89 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Predilife | Paris | Healthcare | Biotechnology & Medical Research | €13.91M | -3.5x | -3.72 | €3.71 | -5.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Plant Advanced Technologies SA | Paris | Healthcare | Biotechnology & Medical Research | €11.55M | €10.35 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
TME Pharma NV | Paris | Healthcare | Biotechnology & Medical Research | €7.94M | -0.4x | -0.02 | €0.08 | -2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Theranexus | Paris | Healthcare | Biotechnology & Medical Research | €7.61M | -4.8x | -0.06 | €0.89 | -3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Oncodesign Precision Medicine | Paris | Healthcare | Biotechnology & Medical Research | €5.78M | -0.9x | -0.05 | €0.32 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Quantum Genomics SA | Paris | Healthcare | Biotechnology & Medical Research | €5.03M | -3.3x | -0.01 | €0.07 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 38.5% Upside | Upgrade to Pro+ | |
Integragen | Paris | Healthcare | Biotechnology & Medical Research | €3.31M | €0.50 | -3.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Biophytis SA | Paris | Healthcare | Biotechnology & Medical Research | €2.76M | -0.1x | -0 | €0.14 | 2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Phaxiam Therapeutics | Paris | Healthcare | Biotechnology & Medical Research | €2.09M | €0.21 | -5.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Geneuro | Paris | Healthcare | Biotechnology & Medical Research | €2.09M | -0.2x | €0.07 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Coretech 5 | Paris | Healthcare | Biotechnology & Medical Research | €1.07M | €0.10 | 25% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Neovacs | Paris | Healthcare | Biotechnology & Medical Research | €4.97K | 0x | €0.002 | -7.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |